The Wyoming Stablecoin Committee has migrated the state-issued Frontier stablecoin (FRNT) from LayerZero to Chainlink's Cross-Chain Interoperability Protocol (CCIP), becoming the first U.S. government entity to publicly change blockchain infrastructure for security reasons. Committee Executive Director Anthony Apollo stated that a security review revealed concerns regarding LayerZero's disclosure practices and operational security, prompting the decision to adopt CCIP to meet stringent security and reliability requirements. This decision comes four months after Kelp DAO's LayerZero cross-chain bridge was hacked for $292 million. Approximately $15 billion in assets have already migrated from LayerZero to Chainlink, including BitGo's transfer of $7.7 billion in wrapped Bitcoin earlier this month. The FRNT has a market cap of less than $1 million and operates across multiple chains, including Ethereum, Base, and Avalanche. It is the only fully-reserved fiat-backed stablecoin issued by a U.S. public entity, with reserve earnings used to support Wyoming school foundation projects.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.




Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.











Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.